Anog, Susan R.
HRN: 28-62-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/16/2026
03/22/2026
IV
4.5G
Q6
CAP MR WITH HAP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines